Signal-transduction inhibitors in renal cell carcinoma

BJU Int. 2007 May;99(5 Pt B):1289-95. doi: 10.1111/j.1464-410X.2007.06833.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Clinical Trials, Phase II as Topic
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Randomized Controlled Trials as Topic
  • Signal Transduction / drug effects*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Protein-Tyrosine Kinases